In the News Items Archive - Page 4 of 4 - Nimbus Therapeutics

Gender tokenism and bias prevail in biotech boardrooms

Editorial: Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL): what makes T-ALL TYK?

Cutting the cancer fat: A Nimbus-designed compound starves tumors of fatty acids

Nimbus Wins $200M Milestone Payment from Gilead toward ACC Inhibitor Program in NASH

Gilead pays Nimbus $200M after fast progress in NASH

Gilead pays $200M milestone to Cambridge biotech Nimbus

Stopping fat synthesis shrinks cancers, study finds

Big Pharma Innovation in Small Places

Gilead to buy Nimbus unit for up to $1.2b

Gilead paying up to $1.2B for Nimbus unit, drug candidate